These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 5309485)

  • 21. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
    Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ
    Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antibody response to trivalent anti-influenza vaccination (inactivated virus) A/Texas/1/77 H3N2), A/URSS/90/77 (H1N1), B/Hong Kong/8/73].
    Mancini G; Andreoni M; Arangio-Ruiz G; Sarrecchia C; Donatelli I; Resta S; Rozera C; Sordillo P; Rocchi G
    Boll Ist Sieroter Milan; 1982 May; 61(2):85-91. PubMed ID: 7126342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Desoxycholate-split influenza vaccines.
    Warburton MF
    Bull World Health Organ; 1969; 41(3):639-41. PubMed ID: 5309488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Universal influenza vaccination and live attenuated influenza vaccination of children.
    Glezen WP
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S104-9. PubMed ID: 18820568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent changes in influenza epidemiology and vaccination recommendations.
    Zimmerman RK
    J Fam Pract; 2005 Jan; 54(1 Suppl):S1-8. PubMed ID: 15623391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The time has come to change the influenza vaccination strategy].
    Kiro A; Mor Z
    Harefuah; 2008 Dec; 147(12):993-4, 1028. PubMed ID: 19260598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The roles of early alert and of adjuvant in the control of Hong Kong influenza by vaccines.
    Hilleman MR
    Bull World Health Organ; 1969; 41(3):623-8. PubMed ID: 4985377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease.
    Mamula P; Markowitz JE; Piccoli DA; Klimov A; Cohen L; Baldassano RN
    Clin Gastroenterol Hepatol; 2007 Jul; 5(7):851-6. PubMed ID: 17544875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influenza vaccine 2008-2009.
    Med Lett Drugs Ther; 2008 Oct; 50(1296):77-9. PubMed ID: 18833032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. History of influenza vaccination programs in Japan.
    Hirota Y; Kaji M
    Vaccine; 2008 Nov; 26(50):6451-4. PubMed ID: 18573292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statement on influenza vaccination for the 1994-95 season.
    CMAJ; 1994 Sep; 151(5):593-603. PubMed ID: 8069804
    [No Abstract]   [Full Text] [Related]  

  • 33. Asthma, influenza, and vaccination.
    Glezen WP
    J Allergy Clin Immunol; 2006 Dec; 118(6):1199-206; quiz 1207-8. PubMed ID: 17157648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flu shot.
    Evans M
    Can Fam Physician; 2005 Nov; 51():1511-2, 1515-6. PubMed ID: 16353833
    [No Abstract]   [Full Text] [Related]  

  • 35. Influenza vaccine in patients with asthma.
    Hanania NA; Atmar RL; Castro M
    Expert Rev Vaccines; 2006 Feb; 5(1):111-8. PubMed ID: 16451113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statement on influenza vaccination for the 2007-2008 season. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2007 Jul; 33(ACS-7):1-38. PubMed ID: 17663034
    [No Abstract]   [Full Text] [Related]  

  • 37. Seed viruses containing novel avian HA and NA antigens for prevention against potential influenza pandemic.
    Li S; Perdue ML; Patzer E
    Dev Biol (Basel); 2002; 110():135-41. PubMed ID: 12477316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
    Desheva JA; Lu XH; Rekstin AR; Rudenko LG; Swayne DE; Cox NJ; Katz JM; Klimov AI
    Vaccine; 2006 Nov; 24(47-48):6859-66. PubMed ID: 17050041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pennsylvania Department of Health advisory. Influenza vaccine recommendations for 1980-81 issued.
    Randall JL
    Pa Med; 1980 Oct; 83(10):14, 16. PubMed ID: 7454352
    [No Abstract]   [Full Text] [Related]  

  • 40. Recombinant vaccines for influenza virus.
    Tripp RA; Tompkins SM
    Curr Opin Investig Drugs; 2008 Aug; 9(8):836-45. PubMed ID: 18666031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.